𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Statement on human papillomavirus DNA test utilization

✍ Scribed by Diane Solomon; Jacalyn L. Papillo; Diane D. Davey

Publisher
Wiley (John Wiley & Sons)
Year
2009
Tongue
English
Weight
142 KB
Volume
117
Category
Article
ISSN
1934-662X

No coin nor oath required. For personal study only.

✦ Synopsis

This statement summarizes the expanded role of human papillomavirus (HPV) testing in the screening and management of cervical cancer. It also highlights circumstances in which HPV testing is not appropriate and may lead to overtreatment.

πŸ“œ SIMILAR VOLUMES

Statement on HPV DNA test utilization
Statement on HPV DNA test utilization
✍ Diane Solomon; Jacalyn L. Papillo; Diane D. Davey πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

Testing for carcinogenic or high-risk human papillomavirus (HPV) DNA has proven utility in cervical cancer screening and in many aspects of clinical management for cervical cancer prevention. However, inappropriate testing increases costs without benefit and potentially results in over-treatment of

Reflex human papillomavirus DNA testing
Reflex human papillomavirus DNA testing on residual liquid-based (TPPTβ„’) cervical samples
✍ Sarode, Venetia Rumnong ;Werner, Claudia ;Gander, Rita ;Foster, Barbara ;Fulmer, πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 94 KB

## Background: Liquid-based thinprep technology has made reflex human papillomavirus (hpv) dna testing possible. in the current study, the clinical performance of reflex hpv testing as an adjunct to routine thinprep testing (tppt) and the impact of age on various test parameters in a predominantly

Population-based study of screening test
Population-based study of screening test performance indices of three human papillomavirus DNA tests
✍ Cecilia WahlstrΓΆm; Thomas Iftner; Joakim Dillner; Lena Dillner πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract In order to evaluate three common human papillomavirus (HPV) DNA tests for key performance indices in population‐based cervical screening, we sampled 12,527 women aged 32–38 years who attended invitational, population‐based screening and followed them for 4 years with comprehensive regi